Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FTC to review Novo Holdings' Catalent buyout for another month
Despite a new 30-day extension on the FTC's review of Novo Holdings' Catalent buyout, the CDMO giant still expects the deal to close by year-end 2024.
Fraiser Kansteiner
May 3, 2024 2:00pm
Incyte's JAK cream Opzelura slows while Leo competition looms
May 3, 2024 10:53am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Merck's BCG monopoly could end
May 3, 2024 10:50am
Sponsored
The biopharma “brain drain”: Finding talent to fuel innovation
Jan 26, 2024 8:00am
GSK plays defense on call to pull popular children's asthma med
May 3, 2024 10:19am